Evidence map›Paper›PMID 19296165›Full record

Trial reportSurgical endoscopy2009

Endoscopic treatment of Roux-en-Y gastric bypass-related gastrocutaneous fistulas using a novel biomaterial.

Fauze Maluf-Filho, Fabio Hondo, Bhawna Halwan, Marcelo Simas de Lima, José Humberto Giordano-Nappi, Paulo Sakai

Abstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Surgical endoscopy, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Major complications of bariatric surgery: endoscopy as first-line treatment.Nature reviews. Gastroenterology & hepatology · 2015
    Review
  16. Article
  17. Article
  18. Endotherapy of leaks and fistula.World journal of gastrointestinal endoscopy · 2015
    Review
  19. Endoscopic Management of Gastrointestinal Fistulae.Gastroenterology & hepatology · 2014
    Article
  20. Confronting gastrocutaneous fistulas.Annals of gastroenterology · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Fauze Maluf-FilhoGastrointestinal Endoscopy Unit, Hospital das Clinicas, University of Sao Paulo Medical School, Sao Paulo, Brazil. fauze.maluf@terra.com.br
Fabio Hondo
Bhawna Halwan
Marcelo Simas de Lima
José Humberto Giordano-Nappi
Paulo Sakai
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRSUNY Downstate Health Sciences University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRoux-en-Y gastric bypass (RYGB) is amongst the commonest surgical intervention for weight loss in obese patients. Gastrocutaneous fistula, which usually occurs along the vertical staple line of the pouch, is amongst its most alarming complications. Medical management comprised of wound drainage, nutritional support, acid suppression, and antibiotics may be ineffective in as many as a third of patients with this complication. We present outcomes after endoscopic application of SurgiSIS, which is a novel biomaterial for the treatment of this complication.

designA case series of 25 patients.

methodsTwenty-five patients who had failed conservative medical management of gastrocutaneous fistula after RYGB underwent endoscopic application of SurgiSIS--an acellular fibrogenic matrix biomaterial to help fistula healing.

main outcome measuresFistula closure as assessed by upper gastrointestinal imaging and endoscopic examination.

resultsIn patients who had failed medical management lasting 4-25 (median, 7) weeks, closure of the fistulous tract was successful after one application in six patients (30%), two applications in 11 patients (55%), and three applications in three patients (15%). There were no procedure-related complications.

conclusionsEndoscopic application of SurgiSIS-an acellular fibrogenic matrix--is safe and effective for the treatment of gastrocutaneous fistula after RYGB.

Indexed as

Gastric BypassTissue ScaffoldsAdultAnimalsAnti-Bacterial AgentsBiocompatible MaterialsCombined Modality TherapyCutaneous FistulaEndoscopyExtracellular MatrixFemaleGastric FistulaHumansMaleMaterials TestingMiddle AgedAnti-Bacterial AgentsBiocompatible MaterialsProton Pump Inhibitors

Identifiers

PMID19296165
OpenAlexW2032210385

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.